← Back to headlines
Mizuho Highlights Amgen Pipeline Potential
Mizuho analysts have highlighted the significant pipeline potential of Amgen (AMGN), specifically mentioning its drugs MariTide and Olpasiran as key future growth drivers.
1 Jul, 10:15 — 1 Jul, 10:15
Sources
Showing 1 of 1 sources
